6533b82efe1ef96bd129268d

RESEARCH PRODUCT

Application of tris-allyl-DOTA in the preparation of DOTA–peptide conjugates

Michael EisenhutCarmen BeckEsther SchirrmacherBjörn WänglerClaudia BauerFrank RöschRalf SchirrmacherUlrike Wagner-utermann

subject

Trischemistry.chemical_classificationOrganic ChemistryPeptideReversed-phase chromatographyBiochemistryCombinatorial chemistrychemistry.chemical_compoundchemistryCyclenMorpholineDrug DiscoveryPeptide synthesisDOTAneoplasmsConjugate

description

Abstract The synthesis of tris-allyl-DOTA starting from cyclen and its application in the preparation of DOTA–peptide conjugates is reported. Clinically important conjugates such as DOTA–Tyr3-octreotide (DOTA–TOC), DOTA–Tyr3-octreotate (DOTA–TATE) as well as a DOTA–RGD peptide were synthesized in high yields with Fmoc solid phase peptide synthesis. The final, extremely reliable de-allylation was achieved on solid phase by different methods identifying morpholine/Pd(0) as the most suitable one obtaining all DOTA peptide conjugates in high yields. All DOTA–peptides were purified by reversed phase HPLC and structural identity was proved using MALDI-TOF mass spectrometry.

https://doi.org/10.1016/j.tetlet.2006.06.022